His lab is working on refining the alanine-scanning assay to a few key residues which can properly distinguish amongst fibrils from neurodegenerative tauopathies. He envisions employing this streamlined assay for postmortem neuropathological diagnosis, And maybe for blood screening of tauopathies.Several colleagues have made the counterargument tha